CNO logo

CNO Financial Group, Inc. Stock Price

NYSE:CNO Community·US$4.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

CNO Share Price Performance

US$0
-36.15 (-100.00%)
US$51.75
Fair Value
US$0
-36.15 (-100.00%)
Price US$0

CNO Community Narratives

·
Fair Value US$51.75 1.9% overvalued intrinsic discount

Aging US Population And Digital Channels Will Expand Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

CNO logo

CNO: Record Highs And Dividend Growth Will Frame A Measured Outlook

Fair Value: US$51.75 1.9% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Established dividend payer and slightly overvalued.

2 Risks
3 Rewards

CNO Financial Group, Inc. Key Details

US$4.5b

Revenue

US$2.8b

Cost of Revenue

US$1.8b

Gross Profit

US$1.5b

Other Expenses

US$245.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
2.63
38.90%
5.44%
172.2%
View Full Analysis

About CNO

Founded
1979
Employees
3300
CEO
Gary Bhojwani
WebsiteView website
www.cnoinc.com

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face with agents. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single-premium deferred annuities; flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees, lesser degree, and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.

Recent CNO News & Updates

Narrative Update Jul 13

CNO: Record Highs And Dividend Growth Will Frame A Measured Outlook

Analysts have nudged their price target on CNO Financial Group higher from $49.50 to $51.75, citing updated fair value estimates, a slightly lower discount rate, modestly adjusted revenue growth expectations, and a higher future P/E assumption as key drivers of the change. What's in the News for CNO Financial Group CNO Financial Group stock recently reached new all time highs, trading in a range from $48.66 to $53.34, with recent price action linked to strong Q1 2026 results and analyst upgrades.
Narrative Update Jun 26

CNO: Highs, Buybacks And Dividend Increases Will Shape A Balanced Outlook

Analysts have maintained their $49.50 price target for CNO Financial Group, making only minor adjustments to assumptions around the discount rate, long term revenue growth, profit margins and future P/E that fine tune rather than significantly change their valuation view. What’s in the News for CNO Financial Group CNO Financial Group stock reached a new all time high of $51.23 after the company reported financial results for Q1 2026 that exceeded analyst expectations on both earnings per share and revenue, according to recent news reports.

Recent updates

No updates